FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2502317411> ?p ?o ?g. }

• W2502317411 endingPage "1857" @default.
• W2502317411 startingPage "1852" @default.
• W2502317411 abstract "Objective. We aimed to evaluate the usefulness of anti-α-fodrin antibodies (AFA) in combination with rheumatoid factor (RF) and/or antinuclear antibodies (ANA) as an alternative immunological criterion for Sjögren syndrome (SS) among patients with negative anti-Ro/La serology. Methods. The study included 350 patients (100 with rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis, and 50 with primary SS) randomly selected and assessed for SS. All patients were tested for ANA, RF, anti-SSA/SSB, and AFA antibodies. SS diagnosis was made on a clinical basis by 2 rheumatologists based on the 6-item screening questionnaire, Schirmer-I test, nonstimulated whole salivary flow rate, fluorescein staining test, autoantibodies, lip biopsy, and medical chart review. Non-SS was defined as lack of clinical diagnosis and not fulfilling the American-European Consensus Group classification criteria and the American College of Rheumatology (ACR) criteria. The ACR criteria were applied substituting the immunological criteria as follows: (1) RF plus ANA > 1:320, (2) RF plus AFA, (3) ANA > 1:320 plus AFA, (4) RF alone, and (5) 2 positive tests out of RF, ANA > 1:320, or AFA. We estimated the sensitivity, specificity, positive predictive value, negative predictive value, and likelihood ratio positivity with 95% CI for each criterion. Results. There were 236 patients (67%) who tested negative for anti-SSA/SSB antibodies, of whom 65 (27.5%) were clinically diagnosed as SS, and 149 (63%) with non-SS. RF + AFA and ANA + AFA performed similarly to RF + ANA > 1:320. The model 2 out of 3 of RF, ANA, or AFA improved the sensitivity from 56.9% to 70.7%, although the specificity decreased. Conclusion. The combination AFA + RF, AFA + ANA > 1:320, or at least 2 out of 3, performed well as a proxy immunological test for patients with SS and negative Ro/La serology." @default.
• W2502317411 created "2016-08-23" @default.
• W2502317411 creator A5004622179 @default.
• W2502317411 creator A5008842237 @default.
• W2502317411 creator A5017427878 @default.
• W2502317411 creator A5026216929 @default.
• W2502317411 creator A5039901118 @default.
• W2502317411 creator A5043212085 @default.
• W2502317411 creator A5056786735 @default.
• W2502317411 creator A5058905477 @default.
• W2502317411 creator A5065646072 @default.
• W2502317411 creator A5078219216 @default.
• W2502317411 date "2016-08-01" @default.
• W2502317411 modified "2023-10-18" @default.
• W2502317411 title "Usefulness of IgA Anti-α-fodrin Antibodies in Combination with Rheumatoid Factor and/or Antinuclear Antibodies as Substitute Immunological Criterion in Sjögren Syndrome with Negative Anti-SSA/SSB Antibodies" @default.
• W2502317411 cites W112689046 @default.
• W2502317411 cites W1895791865 @default.
• W2502317411 cites W1969801895 @default.
• W2502317411 cites W1972200305 @default.
• W2502317411 cites W1989962859 @default.
• W2502317411 cites W2001047384 @default.
• W2502317411 cites W2003586455 @default.
• W2502317411 cites W2005760600 @default.
• W2502317411 cites W2008455986 @default.
• W2502317411 cites W2019358603 @default.
• W2502317411 cites W2026971878 @default.
• W2502317411 cites W2029167801 @default.
• W2502317411 cites W2049631904 @default.
• W2502317411 cites W2063862512 @default.
• W2502317411 cites W2066022831 @default.
• W2502317411 cites W2066260829 @default.
• W2502317411 cites W2066971372 @default.
• W2502317411 cites W2078384109 @default.
• W2502317411 cites W2079750224 @default.
• W2502317411 cites W2091583666 @default.
• W2502317411 cites W2095197048 @default.
• W2502317411 cites W2102709950 @default.
• W2502317411 cites W2111631948 @default.
• W2502317411 cites W2120773157 @default.
• W2502317411 cites W2141569219 @default.
• W2502317411 cites W2167385753 @default.
• W2502317411 cites W752110572 @default.
• W2502317411 doi "https://doi.org/10.3899/jrheum.151315" @default.
• W2502317411 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27481899" @default.
• W2502317411 hasPublicationYear "2016" @default.
• W2502317411 type Work @default.
• W2502317411 sameAs 2502317411 @default.
• W2502317411 citedByCount "10" @default.
• W2502317411 countsByYear W25023174112017 @default.
• W2502317411 countsByYear W25023174112018 @default.
• W2502317411 countsByYear W25023174112019 @default.
• W2502317411 countsByYear W25023174112020 @default.
• W2502317411 countsByYear W25023174112022 @default.
• W2502317411 crossrefType "journal-article" @default.
• W2502317411 hasAuthorship W2502317411A5004622179 @default.
• W2502317411 hasAuthorship W2502317411A5008842237 @default.
• W2502317411 hasAuthorship W2502317411A5017427878 @default.
• W2502317411 hasAuthorship W2502317411A5026216929 @default.
• W2502317411 hasAuthorship W2502317411A5039901118 @default.
• W2502317411 hasAuthorship W2502317411A5043212085 @default.
• W2502317411 hasAuthorship W2502317411A5056786735 @default.
• W2502317411 hasAuthorship W2502317411A5058905477 @default.
• W2502317411 hasAuthorship W2502317411A5065646072 @default.
• W2502317411 hasAuthorship W2502317411A5078219216 @default.
• W2502317411 hasConcept C126322002 @default.
• W2502317411 hasConcept C149443304 @default.
• W2502317411 hasConcept C159654299 @default.
• W2502317411 hasConcept C163764329 @default.
• W2502317411 hasConcept C198451711 @default.
• W2502317411 hasConcept C203014093 @default.
• W2502317411 hasConcept C2776232647 @default.
• W2502317411 hasConcept C2777575956 @default.
• W2502317411 hasConcept C45189115 @default.
• W2502317411 hasConcept C71924100 @default.
• W2502317411 hasConcept C90924648 @default.
• W2502317411 hasConceptScore W2502317411C126322002 @default.
• W2502317411 hasConceptScore W2502317411C149443304 @default.
• W2502317411 hasConceptScore W2502317411C159654299 @default.
• W2502317411 hasConceptScore W2502317411C163764329 @default.
• W2502317411 hasConceptScore W2502317411C198451711 @default.
• W2502317411 hasConceptScore W2502317411C203014093 @default.
• W2502317411 hasConceptScore W2502317411C2776232647 @default.
• W2502317411 hasConceptScore W2502317411C2777575956 @default.
• W2502317411 hasConceptScore W2502317411C45189115 @default.
• W2502317411 hasConceptScore W2502317411C71924100 @default.
• W2502317411 hasConceptScore W2502317411C90924648 @default.
• W2502317411 hasIssue "10" @default.
• W2502317411 hasLocation W25023174111 @default.
• W2502317411 hasLocation W25023174112 @default.
• W2502317411 hasOpenAccess W2502317411 @default.
• W2502317411 hasPrimaryLocation W25023174111 @default.
• W2502317411 hasRelatedWork W1430088 @default.
• W2502317411 hasRelatedWork W1491404397 @default.
• W2502317411 hasRelatedWork W1555832310 @default.
• W2502317411 hasRelatedWork W1596297887 @default.
• W2502317411 hasRelatedWork W1999301958 @default.
• W2502317411 hasRelatedWork W2027411698 @default.
• W2502317411 hasRelatedWork W2042438361 @default.

• next